机译:欧洲和亚洲环境所需的欧洲和亚洲环境需要普遍患病率的地区普遍性的地区中前列腺卫生指数(PHI)的作用的多期评价:欧洲和亚洲环境需要调整PHI参考范围
Erasmus MC Dept Urol Rotterdam Netherlands;
Chinese Univ Hong Kong Prince Wales Hosp Dept Surg Hong Kong Peoples R China;
Univ Clin Munster Prostate Ctr Dept Urol Munster Germany;
Fudan Univ Shanghai Canc Ctr Dept Urol Shanghai Peoples R China;
Hosp Pontchaillou Dept Urol Rennes France;
HIA Du Val De Grace Dept Urol Paris France;
Ist Clin Humanitas IRCCS Dept Urol Rozzano Italy;
Humanitas Univ Dept Urol Rozzano Italy;
Charite Dept Urol Berlin Germany;
Univ Clin Eppendorf Martini Clin Prostate Canc Ctr Hamburg Germany;
Erasmus MC Dept Urol Rotterdam Netherlands;
Chinese Univ Hong Kong Prince Wales Hosp Dept Surg Hong Kong Peoples R China;
Chinese Univ Hong Kong Prince Wales Hosp Dept Surg Hong Kong Peoples R China;
Ist Clin Humanitas IRCCS Dept Urol Rozzano Italy;
Taipei Vet Gen Hosp Dept Surg Yilan Taiwan;
Natl Univ Hlth Syst Univ Surg Cluster Dept Urol Singapore Singapore;
Natl Univ Hlth Syst Univ Surg Cluster Dept Urol Singapore Singapore;
Natl Taiwan Univ Hosp Dept Urol Taipei Taiwan;
China Med Univ Dept Urol Taichung Taiwan;
Erasmus Univ Dept Publ Hlth Med Ctr Rotterdam Netherlands;
Fudan Univ Shanghai Canc Ctr Dept Urol Shanghai Peoples R China;
Erasmus MC Dept Urol Rotterdam Netherlands;
Erasmus MC Dept Urol Rotterdam Netherlands;
Biopsy; Prostate cancer; Prostate health index; -2pro-prostate-specific antigen; Decision curve analysis;
机译:欧洲和亚洲环境所需的欧洲和亚洲环境需要普遍患病率的地区普遍性的地区中前列腺卫生指数(PHI)的作用的多期评价:欧洲和亚洲环境需要调整PHI参考范围
机译:血清前列腺特异性抗原同工型[-2] proPSA(p2PSA)及其衍生物%p2PSA和前列腺健康指数(PHI)在有前列腺癌家族史的男性中的临床表现:一项欧洲多中心研究的结果PROMEtheuS项目
机译:前列腺健康指数(PHI)在肥胖男性中预测前列腺癌的临床表现:来自PROMEtheuS项目的数据,一项欧洲多中心前瞻性研究
机译:基于影像学的DICOM-RT癌症登记系统在评估IMRT治疗前列腺癌的参数中的作用
机译:特殊需要人群的补充和替代药物(CAM)的使用和流行:癌症,乳腺癌,良性前列腺增生和哮喘患者
机译:在4-10 ng / mL的PSA模棱两可的范围内阐明了前列腺健康指数(PHI)和尿激酶纤溶酶原激活剂(uPA)作为前列腺癌的诊断和预测工具的作用
机译:前列腺健康指数(PHI)和尿激酶纤溶酶原激活剂(UPA)作为前列腺癌的诊断和预测工具在4-10ng / ml的范围内诊断和预测工具